Zimbabwe has turned down a substantial American health deal worth 367 million US dollars (272 million pounds) over five years because of the United States' request for sensitive biological samples.
The decision came to light after a official document from December was leaked, which showed President Emmerson Mnangagwa felt the agreement was "lopsided".
An official representative has since stated that the US was seeking genetic material for scientific study and commercial purposes while was not willing to guarantee the resulting advantages from future treatments.
"We must now begin the difficult and regrettable task of winding down our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had donated more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has appealed for more negotiations to find a agreement agreeable to both sides so the nation's critical HIV programme can be sustained.
Broader Background
This rejection comes after a comparable situation in Kenya, where a high court blocked a similar health funding agreement after concerns were raised about the security of citizens' medical information.
Since resuming the presidency last year, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
USAID had administered assistance for the US government, but Trump claimed its spending was "wasteful" and his administration was seeking government-to-government agreements to enhance transparency and responsibility.
As per reports, 16 African countries have to date signed these new health pacts, representing more than $18.3bn of fresh investment.
Details of the Declined Deal
This assistance for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this partnership might have yielded significant advantages for the people of Zimbabwe, especially the 1.2 million presently receiving antiretroviral therapy via American-funded initiatives," Tremont commented.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unequal".
"The proposal required Zimbabwe to provide its biological resources and data for a long time, with no equivalent guarantee of access to any scientific breakthroughs – such as new medicines or tests – that might be developed from that shared data," he stated.
"In essence, our country would provide the raw materials for medical research without any certainty that the resulting innovations would be accessible to our population if a new pandemic emerge."
Sovereignty and Global Health
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were undermining systems already set up through the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to deal with future global health emergencies.
"This framework is intended to guarantee that when a country contributes its samples, the benefits – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the capability to create them."
The government's concerns regarding the US deal "are not meant as opposition to America," Mangwana stressed.
"We are open to ongoing dialogue with our American counterparts on how subsequent collaboration might be designed in a manner that respects the independence and interests of both nations."
Health Experts Reaction
Medical experts stated it recognised the government's concerns, but suggested that talks should continue since a large portion of the country's HIV programmes depended on international support.
"Where technical issues exist, including those involving information security or implementation frameworks, these can frequently be addressed via technical clarification and mutually agreed protections," it added.
The situation highlights the complex tensions between receiving vital foreign assistance and safeguarding local interests in an increasingly interconnected world.